We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Role of Methylphenidate in Psychiatry

Rachel G. Klein, PhD; Paul Wender, MD
Arch Gen Psychiatry. 1995;52(6):429-433. doi:10.1001/archpsyc.1995.03950180015003.
Text Size: A A A
Published online


SOME OF the articles appearing in this issue of the Archives document the current interest in the varied applications of methylphenidate hydrochloride in psychiatry. Together, the articles address questions that have been of concern to clinicians and scientists alike. The scope of the clinical use of methylphenidate in adult psychiatry is addressed in the study by Spencer and associates1; a potentially serious side effect (ie, tics) is examined carefully by Gadow et al2; and Volkow and colleagues3 report on some mechanisms of methylphenidate activity and their contribution to our understanding of the drug's effects.

In an excellent review that appeared in the Archives in 1987, Chiarello and Cole4 summarize the manifold uses of methylphenidate, as well as those of other psychostimulants. Although the literature consisted mostly of less than

See also pages 434, 444, 456, and 464

well-controlled studies conducted in imprecisely identified patient groups, the conclusions pointed to the likely usefulness of psychostimulants


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.